Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Ascendis Pharma
Ascendis Pharma
(ASND)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Skytrofa
Lonapegsomatropin
2021-08-25
Growth and development
Skytrofa (previously lonapegsomatropin ascendis pharma)
Lonapegsomatropin
2022-01-11
Growth and development
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Lonapegsomatropin
healthy volunteers/patients
,
laron syndrome
,
pituitary dwarfism
,
endocrine system diseases
,
failure to thrive
,
turner syndrome
,
pituitary diseases
,
sex chromosome disorders
,
chromosome disorders
,
noonan syndrome
,
dwarfism
,
sex chromosome disorders of sex development
Palopegteriparatide
hypoparathyroidism
,
endocrine system diseases
,
parathyroid diseases
Gilvetmab
neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
carcinoma
,
head and neck neoplasms
,
squamous cell carcinoma of head and neck
,
melanoma
,
squamous cell carcinoma
Aspartame
healthy volunteers/patients
,
colorectal neoplasms
,
chronic renal insufficiency
,
kidney diseases
,
sickle cell anemia
,
knee osteoarthritis
,
osteoarthritis
,
heart failure
,
lung neoplasms
,
ovarian neoplasms
,
sarcoma
,
ovarian epithelial carcinoma
,
head and neck neoplasms
,
squamous cell carcinoma
,
squamous cell neoplasms
,
laryngeal neoplasms
,
opioid-related disorders
,
covid-19
,
coronavirus infections
,
carcinoma
,
neoplasms
,
brain neoplasms
,
glioma
,
neurofibromatosis 2
,
acoustic neuroma
,
meningioma
,
ependymoma
,
neurofibromatosis 1
,
neurofibromatoses
,
neurofibroma
,
neurilemmoma
,
body weight
,
cystic fibrosis
,
melanoma
,
biliary tract neoplasms
,
rare diseases
,
urinary bladder neoplasms
,
invasive hydatidiform mole
,
non-muscle invasive bladder neoplasms
,
non-hodgkin lymphoma
,
b-cell chronic lymphocytic leukemia
,
mantle-cell lymphoma
,
b-cell lymphoma
,
b-cell leukemia
,
diabetes mellitus
,
chronic obstructive pulmonary disease
,
obesity
,
non-small-cell lung carcinoma
,
asthma
,
pulmonary eosinophilia
,
overweight
,
weight loss
,
hyperkalemia
,
nasal polyps
,
endometrial neoplasms
,
borderline personality disorder
,
personality disorders
,
churg-strauss syndrome
,
eosinophilic granuloma
,
type 2 diabetes mellitus
,
breast neoplasms
,
fibrosis
,
inflammation
,
myocarditis
,
endomyocardial fibrosis
,
postoperative pain
,
depression
,
major depressive disorder
,
depressive disorder
,
systemic lupus erythematosus
Bevifimod
phenylketonurias
Nadide
leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
Endocrine
breast neoplasms
,
neoplasms
Mk3475
squamous cell carcinoma of head and neck
,
melanoma
,
recurrence
,
triple negative breast neoplasms
,
renal cell carcinoma
,
neoplasms
,
urologic neoplasms
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
colorectal neoplasms
,
prostatic neoplasms
,
non-small-cell lung carcinoma
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
lung neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use